Current Clinical Trials

Department: Oncology
Diagnosis: Gastrointestinal - Pancreas
Principal Investigator: Lash MD, Bradley
Sub-Investigator(s):
Sponsor: SWOG
Indentifier #: NCT01658943
Title: S1115, Randomized Phase II Clinical Trial of AZD6244 Hydrogen Sulfate (NSC-748727) and MK-2206 (NSC-749607) VS mFOLFOX in Patients with Metastatic Pancreatic Cancer After Prior Chemotherapy
Department: Oncology
Diagnosis: Breast
Principal Investigator: Lynch MD, Cynthia A.
Sub-Investigator(s):
Sponsor: SWOG
Indentifier #: NCT01272037
Title: S1007, A Phase III, Randomized Clinical Trial of Standard Adjuvant Endocrine Therapy +/- Chemotherapy in Patients with 1-3 Positive Nodes, Hormone Receptor-Positive and HER2-Negative Breast Cancer with Recurrence Score (RS) of 25 or Less
Department: Oncology
Diagnosis: Genito-urinary - Renal
Principal Investigator: O'Brien M.D., Edward Thomas
Sub-Investigator(s):
Sponsor: SWOG
Indentifier #: NCT01120249
Title: S0931, EVEREST: EVErolimus for Renal Cancer Ensuing Surgical Therapy, A Phase III Study
Department: Oncology
Diagnosis: Hematology- Leukemia
Principal Investigator: O'Brien M.D., Edward Thomas
Sub-Investigator(s):
Sponsor: Merck & Co.
Indentifier #: NCT01580228
Title: MK-7965 PN 012: A Phase III Study to Evaluate the Efficacy and Safety of Dinaciclib or Ofatumumab in Subjects with Refractory Chronic Lymphocytic Leukemia (CLL).
Department: Oncology
Diagnosis: Lung- Non-Small Cell
Principal Investigator: O'Brien M.D., Edward Thomas
Sub-Investigator(s):
  • Cianfoni CCRP, Michelle
  • Hadlock RN, CCRP, Susan
Sponsor: BMS
Indentifier #: NCT01642004
Title: CA209017, An Open-label Randomized Phase III Trial of BMS-936558 versus Docetaxel in Previously Treated Advanced or Metastatic Squamous Cell Non-small Cell Lung Cancer (NSCLC)
Department: Oncology
Diagnosis: Lung- Non-Small Cell
Principal Investigator: O'Brien M.D., Edward Thomas
Sub-Investigator(s):
Sponsor: BMS
Indentifier #: NCT01285609
Title: CA184104 IDEate, Randomized, Multicenter, Double-Blind, Phase 3 Trial Comparing the Efficacy of Ipilimumab in Addition to Paclitaxel and Carboplatin Versus Placebo in Addition to Paclitaxel and Carboplatin in Subjects With Stage IV/Recurrent Non Small Cell Lung Cancer (NSCLC)
Department: Oncology
Diagnosis: Hematology- Lymphoma
Principal Investigator: Srivatana M.D., Panit
Sub-Investigator(s):
Sponsor: Millenium Pharmaceutical
Indentifier #: NCT00931918
Title: C05013, An Open-Label, Randomized, Phase 2 Study to Assess the Effectiveness of RCHOP With or Without VELCADE in Previously Untreated Non-Germinal Center B-Cell-like Diffuse Large B-Cell Lymphoma Patients.
Department: Oncology
Diagnosis: Hematology- Lymphoma
Principal Investigator: O'Brien M.D., Edward Thomas
Sub-Investigator(s):
Sponsor: Pfizer
Indentifier #: NCT01232556
Title: B1931008, An Open-Label, Randomized, Phase 3 Study Of Inotuzumab Ozogamicin Administered In Combination With Rituximab Compared To Defined Investigator's Choice Therapy In Subjects With Relapsed Or Refractory CD22-Positive Aggressive Non-Hodgkin Lymphoma Who Are Not Candidates For Intensive High-Dose Chemotherapy
Department: Oncology
Diagnosis: Gastrointestinal - Pancreas
Principal Investigator: O'Brien M.D., Edward Thomas
Sub-Investigator(s):
Sponsor: Pfizer
Indentifier #: NCT01525550
Title: A6181202, A Single Arm Open-Label International Multi Center Study Of The Efficacy And Safety Of Sunitinib Malate (SU011248, Sutent®) In Patients With Progressive Advanced Metastatic Well Differentiated Unresectable Pancreatic Neuroendocrine Tumors
Department: Oncology
Diagnosis: Lung- Non-Small Cell
Principal Investigator: O'Brien M.D., Edward Thomas
Sub-Investigator(s):
  • Cianfoni CCRP, Michelle
  • Hadlock RN, CCRP, Susan
Sponsor: BMS
Indentifier #: NCT01673867
Title: CA209057, An Open-Label Randomized Phase III Trial of BMS-936558 versus Docetaxel in Previously Treated Advanced or Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC)

Pages